rs397516300

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM1PM5BP4BP6

The NM_000260.4(MYO7A):​c.3469A>G​(p.Ile1157Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000338 in 1,598,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1157N) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000032 ( 0 hom. )

Consequence

MYO7A
NM_000260.4 missense

Scores

12
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 2.93

Publications

1 publications found
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
MYO7A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, PanelApp Australia
  • Usher syndrome type 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant nonsyndromic hearing loss 11
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 6 uncertain in NM_000260.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-77184682-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 2580433.
BP4
Computational evidence support a benign effect (MetaRNN=0.41703022).
BP6
Variant 11-77184681-A-G is Benign according to our data. Variant chr11-77184681-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 43204.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO7ANM_000260.4 linkc.3469A>G p.Ile1157Val missense_variant Exon 27 of 49 ENST00000409709.9 NP_000251.3 Q13402-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO7AENST00000409709.9 linkc.3469A>G p.Ile1157Val missense_variant Exon 27 of 49 1 NM_000260.4 ENSP00000386331.3 Q13402-1
MYO7AENST00000458637.6 linkc.3469A>G p.Ile1157Val missense_variant Exon 27 of 49 1 ENSP00000392185.2 Q13402-2
MYO7AENST00000409619.6 linkc.3436A>G p.Ile1146Val missense_variant Exon 28 of 50 1 ENSP00000386635.2 Q13402-8
MYO7AENST00000458169.2 linkc.1012A>G p.Ile338Val missense_variant Exon 7 of 29 1 ENSP00000417017.2 H7C4D8
MYO7AENST00000670577.1 linkn.1309A>G non_coding_transcript_exon_variant Exon 10 of 32 ENSP00000499323.1 A0A590UJ94

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152234
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000313
AC:
7
AN:
223622
AF XY:
0.0000330
show subpopulations
Gnomad AFR exome
AF:
0.0000748
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000104
Gnomad NFE exome
AF:
0.0000302
Gnomad OTH exome
AF:
0.000178
GnomAD4 exome
AF:
0.0000325
AC:
47
AN:
1446662
Hom.:
0
Cov.:
31
AF XY:
0.0000306
AC XY:
22
AN XY:
718094
show subpopulations
African (AFR)
AF:
0.0000301
AC:
1
AN:
33198
American (AMR)
AF:
0.00
AC:
0
AN:
42566
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25924
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84068
European-Finnish (FIN)
AF:
0.000484
AC:
25
AN:
51668
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000163
AC:
18
AN:
1104474
Other (OTH)
AF:
0.0000502
AC:
3
AN:
59802
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152234
Hom.:
0
Cov.:
33
AF XY:
0.0000672
AC XY:
5
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41462
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000660
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000497
AC:
6

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Nov 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1157 of the MYO7A protein (p.Ile1157Val). This variant is present in population databases (rs397516300, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MYO7A-related conditions. ClinVar contains an entry for this variant (Variation ID: 43204). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MYO7A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Benign:1
Aug 11, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ile1157Val in exon 27A of MYO7A: This variant is not expected to have clinical s ignificance due to a lack of conservation across species, including mammals. Of note, 12 mammals have a valine (Val) at this position despite high nearby amino acid conservation. In addition, computational analyses do not suggest a high lik elihood of impact to the protein. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.48
T;T;.;.;.;T
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.89
D;D;D;D;D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.42
T;T;T;T;T;T
MetaSVM
Uncertain
0.72
D
MutationAssessor
Uncertain
2.4
M;.;M;.;.;.
PhyloP100
2.9
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.96
N;.;N;N;.;N
REVEL
Uncertain
0.56
Sift
Uncertain
0.017
D;.;D;D;.;D
Sift4G
Uncertain
0.015
D;D;D;D;.;D
Polyphen
1.0
D;.;.;.;.;.
Vest4
0.36
MutPred
0.76
Loss of ubiquitination at K1153 (P = 0.1139);.;Loss of ubiquitination at K1153 (P = 0.1139);.;.;.;
MVP
0.88
MPC
0.075
ClinPred
0.088
T
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.40
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397516300; hg19: chr11-76895726; API